Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-29 4:30 pm Sale | 13G | ACHILLES THERAPEUTICS PLC ACHL | Artal International S.C.A. | 755,375 1.9% | -1,500,000 (-66.51%) | View |
| 2024-03-29 4:30 pm Unchanged | 13G | VIGIL NEUROSCIENCE INC VIGL | Artal International S.C.A. | 1,811,191 4.9% | 0 (Unchanged) | View |
| 2024-02-09 5:16 pm Sale | 13G | APTINYX INC APTX | Artal International S.C.A. | 0 0% | -6,116,493 (Position Closed) | View |
| 2024-02-09 5:14 pm Sale | 13G | VERSARTIS INC ARAV | Artal International S.C.A. | 7,609,522 9.4% | -4,572,515 (-37.53%) | View |
| 2024-02-09 5:14 pm Purchase | 13G | SCHOLAR ROCK HLDG CORP SRRK | Artal International S.C.A. | 12,834,446 17.4% | 2,279,168 (+21.59%) | View |
| 2024-02-09 5:13 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | Artal International S.C.A. | 10,455,849 6.4% | 248,859 (+2.44%) | View |
| 2024-02-09 5:13 pm Sale | 13G | VIGIL NEUROSCIENCE INC VIGL | Artal International S.C.A. | 1,811,191 5% | -432,161 (-19.26%) | View |
| 2024-02-09 5:12 pm Purchase | 13G | ALLOVIR INC ALVR | Artal International S.C.A. | 6,597,167 5.8% | 1,020,000 (+18.29%) | View |
| 2024-02-09 5:11 pm Purchase | 13G | IGM BIOSCIENCES INC IGMS | Artal International S.C.A. | 3,100,422 9.4% | 650,422 (+26.55%) | View |
| 2024-02-09 5:11 pm Unchanged | 13G | AGENUS INC AGEN | Artal International S.C.A. | 15,631,235 4.1% | 0 (Unchanged) | View |
| 2024-02-09 5:10 pm Sale | 13G | SQZ BIOTECHNOLOGIES CO COM SQZ | Artal International S.C.A. | 1,141,309 3.9% | -465,000 (-28.95%) | View |
| 2024-02-09 5:09 pm Sale | 13G | HARPOON THERAPEUTICS INC HARP | Artal International S.C.A. | 2,038,870 9.9% | -308,567 (-13.14%) | View |
| 2024-02-09 5:08 pm Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | Artal International S.C.A. | 3,568,842 9.9% | 2,105,013 (+143.80%) | View |
| 2024-02-09 5:08 pm Sale | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Artal International S.C.A. | 0 0% | -15,066,043 (Position Closed) | View |
| 2024-02-09 5:07 pm Sale | 13G | NANOBIOTIX S A SPONSORED ADS NBTX | Artal International S.C.A. | 0 0% | -3,069,034 (Position Closed) | View |
| 2024-02-09 5:06 pm Sale | 13G | MORPHIC HLDG INC MORF | Artal International S.C.A. | 2,138,188 4.3% | -11,812 (-0.55%) | View |
| 2024-02-09 5:06 pm Sale | 13G | CYCLERION THERAPEUTICS INC CYCN | Artal International S.C.A. | 138,955 5.7% | -2,640,167 (-95.00%) | View |
| 2024-02-09 5:05 pm Purchase | 13G | SILENCE THERAPEUTICS PLC SPONS SLN | Artal International S.C.A. | 9,000,000 7.8% | 1,500,000 (+20.00%) | View |
| 2024-02-09 5:04 pm Purchase | 13G | CAVA GROUP INC CAVA | Artal International S.C.A. | 32,007,990 28.2% | 32,007,990 (New Position) | View |
| 2024-02-09 5:03 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | Artal International S.C.A. | 8,589,064 13.3% | 2,015,266 (+30.66%) | View |